What if the secret to building a top-performing app wasn’t a growth hack, but a smarter way to listen to your users?

In this episode, we sit down with Claire McGregor, Co-founder & Co-CEO of Fortify, Appbot and tiny ideas, to explore how she’s helping thousands of product teams transform raw customer feedback into strategic insights that drive real app success.

Claire shares the journey behind building Fortify into a globally trusted platform for sentiment analysis and review intelligence. She walks us through how leading companies—from scrappy startups to enterprise giants—use feedback data to prioritize features, reduce churn, and build experiences users love.

The conversation dives into the realities of scaling a SaaS business, the mindset required for durable founder partnerships, and why obsessing over customer sentiment is one of the biggest competitive advantages in today’s app ecosystem.

• How Fortify turns scattered customer reviews into actionable product insights
• The most overlooked opportunities hidden inside app store feedback
• Why user sentiment is a more reliable north star than downloads
• Common mistakes app teams make when interpreting customer data
• How Claire balances intuition and analytics when making product decisions
• The dynamics of co-founding a global SaaS company and how to keep it healthy
• What Claire looks for as an investor, and the red flags she avoids
• How “tiny ideas” can become scalable, sustainable businesses

“Your customers are already telling you how to win—most teams just aren’t listening closely enough.”

LinkedIn: linkedin.com/in/clairecmcgregor

Connect with the Show:

• LinkedIn
• Website
• Spotify
• Amazon Music
• iHeart

Subscribe on Spotify, Apple Podcasts, or your favorite platform.

If you enjoyed this episode, share it with someone passionate about healthcare marketing, startup growth, or innovative product launches, and don’t forget to leave us a review. New episodes drop weekly!

What if your body could sense pain and block it, no pills, no patches, no addiction, just smart biology + AI?

In this episode of Lightning RX, host Kalena Taft, founder of Lightning GTM, sits down with Alexander Ziwahatan, President at Omnithion, to explore how his team is developing OmniDots, AI-powered micro-injectables designed to find and silence pain signals from within the body.

Alexander shares how his 17 years as a caregiver to his mother, who has endured numerous back surgeries, ignited his drive to build a better solution. Instead of relying on systemic drugs with side effects, he envisions microscopic serums that travel through the bloodstream, detect pain, and block it precisely at its source.

He delves into the technology, the vision, and the hurdles ahead: human trials, regulatory pathways, industry skepticism, and the mission to transform how pain is managed, especially as the opioid crisis continues to devastate communities.

What You’ll Learn:

• The origin story behind OmniDots and how personal experience sparked the idea
• How AI and injectable technology might identify and intercept pain signals
• The potential to replace traditional pain meds with smarter, safer alternatives
• The challenges of getting a novel medical technology from concept to clinic
• How to build partnerships when funding, scale, and credibility are still in progress
• Why mission must lead innovation when the stakes are human suffering
• The mindset of a founder working to change the entire paradigm of chronic pain

💡 Golden Nugget:

“OmniDots isn’t just a product, it’s hope. It’s the future of treating pain without addiction.”

Connect with Alexander Ziwahatan

• Website: omnithion.org
• Facebook: https://web.facebook.com/alexander.ziwahatan/?_rdc=1&_rdr#
• Bio: https://www.votealex.org/
• LinkedIn: https://www.linkedin.com/in/ziwahatan/

Connect with the Show:

• LinkedIn
• Website
• Spotify
• Amazon Music
• iHeart

Subscribe on Spotify, Apple Podcasts, or your favorite platform.

If you enjoyed this episode, share it with someone passionate about healthcare marketing, startup growth, or innovative product launches, and don’t forget to leave us a review. New episodes drop weekly!

What if the future of chemistry didn’t rely on cells or even nature itself to create the world’s most valuable molecules?

In this episode of Lightning RX, host Colette Nataf sits down with Michael Heltzen, CEO of eXoZymes Inc. (Nasdaq: EXOZ), to explore how his company is redefining biomanufacturing through exozymes, a revolutionary technology that uses AI-driven evolution to create natural products at an industrial scale, without harvesting from nature.

Michael explains how eXoZymes’ cell-free biomanufacturing platform allows them to “brute-force evolution,” running what would take nature a billion years in just a week. By combining artificial intelligence with enzymatic chemistry, the company can produce rare and valuable natural compounds—like the metabolism-boosting molecule NCT and the fragrance powerhouse Santaline that were previously inaccessible due to scarcity or cost.

From AI-guided protein optimization to sustainable alternatives to petrochemicals, Michael’s work represents a new frontier in synthetic biochemistry, one that merges environmental responsibility, efficiency, and scientific creativity.

What You’ll Learn:

• How eXoZymes is reinventing biomanufacturing through cell-free enzyme systems
• Why AI models like AlphaFold are unlocking rapid protein optimization
• The science behind producing rare natural compounds like NCT and Santaline
• How enzyme optimization accelerates evolution from millennia to minutes
• The potential of biomanufacturing to replace petrochemicals and protect ecosystems
• Why scarcity is no longer the barrier to accessing nature’s rarest molecules
• How eXoZymes balances scientific innovation with commercial scalability
• Michael’s advice for founders on choosing the right advisors and staying focused amid conflicting guidance

💡 Golden Nugget:

“AI and enzymes are teaching us that evolution isn’t just a process, it’s a platform we can engineer for sustainable abundance.”

Connect with Michael Heltzen

• LinkedIn: linkedin.com/in/michaelheltzen
• Company: https://exozymes.com/

Connect with the Show:

• LinkedIn
• Website
• Spotify
• Amazon Music
• iHeart

Subscribe on Spotify, Apple Podcasts, or your favorite platform.

If you enjoyed this episode, share it with someone passionate about healthcare marketing, startup growth, or innovative product launches, and don’t forget to leave us a review. New episodes drop weekly!